GB0127832D0 - Method for the preparation of pharmaceutical nanosuspensions - Google Patents

Method for the preparation of pharmaceutical nanosuspensions

Info

Publication number
GB0127832D0
GB0127832D0 GB0127832A GB0127832A GB0127832D0 GB 0127832 D0 GB0127832 D0 GB 0127832D0 GB 0127832 A GB0127832 A GB 0127832A GB 0127832 A GB0127832 A GB 0127832A GB 0127832 D0 GB0127832 D0 GB 0127832D0
Authority
GB
United Kingdom
Prior art keywords
preparation
nanosuspensions
pharmaceutical
pharmaceutical nanosuspensions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0127832A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Priority to GB0127832A priority Critical patent/GB0127832D0/en
Publication of GB0127832D0 publication Critical patent/GB0127832D0/en
Priority to PCT/GB2002/005187 priority patent/WO2003045353A1/en
Priority to AU2002343033A priority patent/AU2002343033A1/en
Ceased legal-status Critical Current

Links

GB0127832A 2001-11-20 2001-11-20 Method for the preparation of pharmaceutical nanosuspensions Ceased GB0127832D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0127832A GB0127832D0 (en) 2001-11-20 2001-11-20 Method for the preparation of pharmaceutical nanosuspensions
PCT/GB2002/005187 WO2003045353A1 (en) 2001-11-20 2002-11-19 Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow
AU2002343033A AU2002343033A1 (en) 2001-11-20 2002-11-19 Method for the preparation of pharmaceutical nanosuspensions using supersonic fluid flow

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0127832A GB0127832D0 (en) 2001-11-20 2001-11-20 Method for the preparation of pharmaceutical nanosuspensions

Publications (1)

Publication Number Publication Date
GB0127832D0 true GB0127832D0 (en) 2002-01-09

Family

ID=9926133

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0127832A Ceased GB0127832D0 (en) 2001-11-20 2001-11-20 Method for the preparation of pharmaceutical nanosuspensions

Country Status (3)

Country Link
AU (1) AU2002343033A1 (en)
GB (1) GB0127832D0 (en)
WO (1) WO2003045353A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007000308A (en) * 2004-07-01 2007-04-10 Warner Lambert Co Preparation of pharmaceutical compositions containing nanoparticles.
DE102005005433B4 (en) 2005-02-05 2006-10-19 RST Gesellschaft für Wasserspartechnik mbH flow regulator
JP5483874B2 (en) * 2005-05-05 2014-05-07 サノフィ−アベンティス・ユー・エス・エルエルシー Stable nanoparticle formulation
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
US9114077B2 (en) 2006-11-17 2015-08-25 Abbvie Deutschland Gmbh & Co Kg Nanocrystals for use in topical cosmetic formulations and method of production thereof
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
WO2008128995A1 (en) 2007-04-23 2008-10-30 Janssen Pharmaceutica N.V. 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663299A (en) 2007-04-23 2010-03-03 詹森药业有限公司 Thiophene (two) azole compounds as fast dissociating dopamine 2 receptor antagonists
BRPI0916333A2 (en) 2008-07-31 2016-02-16 Janssen Pharmaceutica Nv piperazin-1-yl-trifluoromethyl-substituted pyridines as rapidly dissociating dopamine 2 receptor antagonists
US9364438B2 (en) 2012-09-26 2016-06-14 Takeda Pharmaceutical Company Limited Process for producing solid particles
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
AU2020259406A1 (en) 2019-04-17 2021-11-04 Compass Pathfinder Limited Treatment of depression and other various disorders with psilocybin
CN112691087B (en) * 2021-01-25 2022-02-25 潍坊医学院 Natamycin nanoparticles and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720551A (en) * 1994-10-28 1998-02-24 Shechter; Tal Forming emulsions
DE4440337A1 (en) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmaceutical nanosuspensions for drug application as systems with increased saturation solubility and dissolution rate
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
AU719085B2 (en) * 1996-08-22 2000-05-04 Rtp Pharma Corporation Processes of preparing or stabilising microparticles
KR100644172B1 (en) * 1998-05-25 2006-11-10 니뽄 신야쿠 가부시키가이샤 Process for producing composite preparation containing nucleic acid
US6443610B1 (en) * 1998-12-23 2002-09-03 B.E.E. International Processing product components
KR100801588B1 (en) * 1999-09-21 2008-02-05 스키에파마 캐나다 인코포레이티드 Surface Modified Particulate Compositions of Biological Active Substances
NZ522239A (en) * 2000-04-20 2004-03-26 Skyepharma Canada Inc Improved water-insoluble drug particle process
GB0114532D0 (en) * 2001-06-14 2001-08-08 Jagotec Ag Novel compositions

Also Published As

Publication number Publication date
WO2003045353A1 (en) 2003-06-05
AU2002343033A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
HK1052183A1 (en) Method for the preparation of tetrahydrobenzothiepines
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
GB0102342D0 (en) Pharmaceutical formulation
GB0117618D0 (en) Pharmaceutical dosage form
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
GB0118689D0 (en) Pharmaceutical formulation
HK1068887A1 (en) Method for the preparation of hexahydro-furo
GB0117619D0 (en) Pharmaceutical dosage form
GC0000391A (en) Process for the preparation of urea
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003221699A8 (en) Pharmaceutical preparation for taste masking
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
GB0101227D0 (en) Pharmaceutical compounds
GB0101225D0 (en) Pharmaceutical compounds
GB0127832D0 (en) Method for the preparation of pharmaceutical nanosuspensions
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
IL162385A0 (en) Process for the preparation of echinocandin derivatives
PT1446107E (en) Process for the preparation of tablets comprising s-adenosylmethionine
SG120874A1 (en) Process for the preparation of peptides
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
AU2002337601A1 (en) Process for the preparation of simvastatin
MXPA03009210A (en) New process for the preparation of oxabispidines.
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2002342940A8 (en) New pharmaceutical compounds
HUP0201992A3 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing the compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)